Clinical Trial Update: Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the Chinese herbal formula SS-1 for modulating immunity-related gene expression in Sjögren's Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• SS-1

Snippet

Sponsor: China Medical University Hospital | Conditions: Sjögren's Syndrome | Phase 2 | Status: UNKNOWN